Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Lotter

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
British Journal of Haematology|July 18, 2024
Safety and efficacy of immunosuppressive therapy for elderly patients with severe aplastic anaemiaAshvind Prabahran, Jibran Durrani, Juan Coelho-Da Silva, et al.
Leukemia|April 22, 2026
Imputing causality and clonal dynamics from single-cell transcriptomics in paroxysmal nocturnal hemoglobinuriaHiroki Mizumaki, Shouguo Gao, Zhijie Wu, et al.
Blood|December 1, 2020
Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccinesChristopher Pleyer, Mir A Ali, Jeffrey I Cohen, et al.
Blood Advances|October 20, 2025
Danazol treatment for telomere biology disorders: long-term results of a phase 1/2 studyNicholas C Lee, Fernanda Gutierrez-Rodrigues, Ruba Shalhoub, et al.
Blood Advances|February 14, 2022
BTK inhibitors impair humoral and cellular responses to recombinant zoster vaccine in CLLChristopher Pleyer, Kerry J Laing, Mir A Ali, et al.
American Journal of Hematology|August 19, 2020
A phase II study of ibrutinib and short-course fludarabine in previously untreated patients with chronic lymphocytic leukemiaChristopher Pleyer, Xin Tian, Shakuntala Rampertaap, et al.
The New England Journal of Medicine|April 20, 2017
Eltrombopag Added to Standard Immunosuppression for Aplastic AnemiaDanielle M Townsley, Phillip Scheinberg, Thomas Winkler, et al.
Blood Advances|March 14, 2025
Impact of HLA alloimmunization on clinical outcomes of severe aplastic anemia treated with immunosuppressive therapyJibran Durrani, Leonard N Chen, Ruba N Shalhoub, et al.
Blood|April 18, 2019
Treatment optimization and genomic outcomes in refractory severe aplastic anemia treated with eltrombopagThomas Winkler, Xing Fan, James Cooper, et al.
Blood Advances|April 25, 2020
Eltrombopag for patients with moderate aplastic anemia or uni-lineage cytopeniasXing Fan, Ronan Desmond, Thomas Winkler, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
British Journal of Haematology|July 18, 2024
Safety and efficacy of immunosuppressive therapy for elderly patients with severe aplastic anaemiaAshvind Prabahran, Jibran Durrani, Juan Coelho-Da Silva, et al.
Leukemia|April 22, 2026
Imputing causality and clonal dynamics from single-cell transcriptomics in paroxysmal nocturnal hemoglobinuriaHiroki Mizumaki, Shouguo Gao, Zhijie Wu, et al.
Blood|December 1, 2020
Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccinesChristopher Pleyer, Mir A Ali, Jeffrey I Cohen, et al.
Blood Advances|October 20, 2025
Danazol treatment for telomere biology disorders: long-term results of a phase 1/2 studyNicholas C Lee, Fernanda Gutierrez-Rodrigues, Ruba Shalhoub, et al.
Blood Advances|February 14, 2022
BTK inhibitors impair humoral and cellular responses to recombinant zoster vaccine in CLLChristopher Pleyer, Kerry J Laing, Mir A Ali, et al.
American Journal of Hematology|August 19, 2020
A phase II study of ibrutinib and short-course fludarabine in previously untreated patients with chronic lymphocytic leukemiaChristopher Pleyer, Xin Tian, Shakuntala Rampertaap, et al.
The New England Journal of Medicine|April 20, 2017
Eltrombopag Added to Standard Immunosuppression for Aplastic AnemiaDanielle M Townsley, Phillip Scheinberg, Thomas Winkler, et al.
Blood Advances|March 14, 2025
Impact of HLA alloimmunization on clinical outcomes of severe aplastic anemia treated with immunosuppressive therapyJibran Durrani, Leonard N Chen, Ruba N Shalhoub, et al.
Blood|April 18, 2019
Treatment optimization and genomic outcomes in refractory severe aplastic anemia treated with eltrombopagThomas Winkler, Xing Fan, James Cooper, et al.
Blood Advances|April 25, 2020
Eltrombopag for patients with moderate aplastic anemia or uni-lineage cytopeniasXing Fan, Ronan Desmond, Thomas Winkler, et al.
Pageof 3